1. Home
  2. QMCO vs CRBP Comparison

QMCO vs CRBP Comparison

Compare QMCO & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QMCO
  • CRBP
  • Stock Information
  • Founded
  • QMCO 1980
  • CRBP 2009
  • Country
  • QMCO United States
  • CRBP United States
  • Employees
  • QMCO N/A
  • CRBP N/A
  • Industry
  • QMCO Electronic Components
  • CRBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • QMCO Technology
  • CRBP Health Care
  • Exchange
  • QMCO Nasdaq
  • CRBP Nasdaq
  • Market Cap
  • QMCO 80.0M
  • CRBP 73.4M
  • IPO Year
  • QMCO N/A
  • CRBP N/A
  • Fundamental
  • Price
  • QMCO $11.50
  • CRBP $7.23
  • Analyst Decision
  • QMCO Hold
  • CRBP Strong Buy
  • Analyst Count
  • QMCO 2
  • CRBP 10
  • Target Price
  • QMCO $19.00
  • CRBP $53.56
  • AVG Volume (30 Days)
  • QMCO 2.8M
  • CRBP 114.7K
  • Earning Date
  • QMCO 06-16-2025
  • CRBP 05-06-2025
  • Dividend Yield
  • QMCO N/A
  • CRBP N/A
  • EPS Growth
  • QMCO N/A
  • CRBP N/A
  • EPS
  • QMCO N/A
  • CRBP N/A
  • Revenue
  • QMCO $285,865,000.00
  • CRBP N/A
  • Revenue This Year
  • QMCO N/A
  • CRBP N/A
  • Revenue Next Year
  • QMCO $2.46
  • CRBP $150.00
  • P/E Ratio
  • QMCO N/A
  • CRBP N/A
  • Revenue Growth
  • QMCO N/A
  • CRBP N/A
  • 52 Week Low
  • QMCO $2.22
  • CRBP $4.64
  • 52 Week High
  • QMCO $90.64
  • CRBP $61.90
  • Technical
  • Relative Strength Index (RSI)
  • QMCO 47.42
  • CRBP 51.77
  • Support Level
  • QMCO $11.06
  • CRBP $7.05
  • Resistance Level
  • QMCO $14.29
  • CRBP $7.62
  • Average True Range (ATR)
  • QMCO 1.56
  • CRBP 0.49
  • MACD
  • QMCO 0.07
  • CRBP -0.02
  • Stochastic Oscillator
  • QMCO 30.23
  • CRBP 38.97

About QMCO Quantum Corporation

Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data. The company provides solutions for the entire data lifecycle. The company specialize in solutions for video, images, audio, and other large files. The company's portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The company's Primary Storage Software and Systems include Myriad All-Flash Software-Defined Storage, StorNext Hybrid Flash/Disk File Storage Software, and Unified Surveillance Platform Software. Secondary Storage Software and Systems include ActiveScale Object Storage Software and DXi Backup Appliances. The firm derives the majority of its revenue from United States.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: